HSP90 had been reported to impact the cell cycle of VSMCs in atherosclerosis progression, and as such we proceeded to investigate the impact of 17-AAG-treatment on cell cycle progression in PASMCs. This evidence concerns the gene HSP90AA1 and atherosclerosis.